Purchase Order 75N91020P00229

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute issued a $32,582.74 delivery order to Life Technologies Corporation on September 17, 2018, for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers.</p> <p>Place of performance is Grand Island, NY. The order has a ceiling value of $32,582.74 with an ultimate completion date of September 24, 2018. Pricing is firm fixed price. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biological kits valued at $14,923.40 on August 24, 2020, with an ultimate completion date of September 23, 2020. Place of performance is Carlsbad, California. The order carries firm fixed pricing with no set-aside designation.</p>

The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $24,095.00 on August 6, 2021, for EVOS M5000 DSS equipment with a one-year reorder exchange provision. The order was issued to administratively de-obligate unexpiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) prior to the September 30, 2021 close of the fiscal year period of availability. Performance occurs at Grand Island, New York. The purchase order carries firm...

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

The National Cancer Institute issued a delivery order to Life Technologies Corporation on June 6, 2019, with a ceiling value of $43,354.52 for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers. Place of performance is Grand Island, NY. The order is firm fixed price with an ultimate completion date of July 6, 2019. Life Technologies Corporation is a subsidiary of Thermo Fisher Scientific Inc. and specializes in biomedical research and genetic analysis...

The National Cancer Institute issued a delivery order to Life Technologies Corporation on January 25, 2019, with a ceiling value of $45,930.66 for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers. Place of performance is Grand Island, NY. The order is priced on a firm fixed price basis and has an ultimate completion date of February 28, 2019. Life Technologies Corporation is a subsidiary of Thermo Fisher Scientific Inc. and a leading provider of...

<p>The NIH Clinical Center awarded a purchase order to Life Technologies Corporation on March 23, 2020, for $12,454.11 on a firm fixed-price basis, with an ultimate completion date of March 27, 2020. Place of performance is Grand Island, New York. The order carries no set-aside designation.</p>

The National Cancer Institute awarded a $19,905 firm fixed-price purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on December 2, 2024, with an ultimate completion date of November 1, 2025. This contract is part of the FY26 UDO Initiative and was issued without set-aside designation, reflecting open competitive procurement. Life Technologies Corporation, headquartered in Carlsbad, California, is a leading supplier of scientific instrumentation, reagents, and...

<p>The National Cancer Institute issued a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) valued at $10,412.00 on July 1, 2020, for biological kits. Place of performance is Carlsbad, California. The order is firm fixed price with an ultimate completion date of July 31, 2020. No set-aside was used.</p>